Practice question

Answer the question and get instant feedback.

MediumCardiologyPost-PCI Antiplatelet Therapyus-usmle-step-2us-abimus-abfm

A 62-year-old with stable ischemic heart disease receives a contemporary drug-eluting stent for a non-ACS lesion. Which antiplatelet duration is most appropriate absent high bleeding risk?

Educational content. Not a substitute for clinical judgement or local policy.